Please use this identifier to cite or link to this item:
|Title:||ASSERT trial – How to assess the safety and efficacy of a high frequency rTMS in postpartum depression ? A multicenter, double blinded, randomized, placebo-controlled clinical trial||Autores:||Andriotti, T.
Fakhry Tonos, Stephanie
Ganho- Avila, A.
Hirayama, A. L.
Smith-Howard, T. P.
Campoverde Reyes, K.
|Researchers (UNIBE):||Fakhry Tonos, Stephanie||Affiliations:||Facultad de Ciencias de la Salud||Research area:||Ciencias de la Salud||Keywords:||Postpartum depression; Repetitive Transcranial Magnetic Stimulation; Research clinical trial||Issue Date:||2017||Publisher:||Elsevier Inc.||Source:||Contemporary Clinical Trials, 5, 86-91.||Journal:||Contemporary Clinical Trials||Volume:||5||Start page:||86||End page:||81||Abstract:||
Background: Postpartum Depression affects a considerable number of women worldwide. This condition inflicts severe consequences to mother and child health. Thus far, available treatments have low response and high relapse rates. We designed this trial to evaluate a safe and more efficacious innovative therapy.
Aims: To report a feasible and ethical study design to assess the safety and efficacy of a high frequency repetitive Transcranial Magnetic Stimulation 10 Hz (rTMS) compared to sham rTMS in women with moderate to severe Post-Partum Depression using standard treatment (sertraline).To conduct an ancillary, exploratory, randomized, active controlled, double blind study with a hypothesis to assess the safety and efficacy of 10 Hz rTMS compared to sertraline.
Methods: A multicenter, parallel arm, randomized, placebo-controlled, double-blind design to assess safety and efficacy of 10 Hz rTMS compared to sham.An ancillary study will be conducted with parallel arm, randomized, active controlled and double dummy design to assess safety and efficacy of 10 Hz rTMS compared to sertraline.
|Appears in Collections:||Publicaciones de la Facultad de Ciencias de la Salud|
Show full item record Recommend this item
Files in This Item:
This item is licensed under a Creative Commons License